Keele Research Repository
Explore the Repository
Chufal, KS, Ahmad, I, Bajpai, R, Miller, AA, Chowdhary, RL, Makker, J, Batra, U, Nathany, S, Sharief, MI, Umesh, P, Sharma, M, Amrith, P, Pahuja, AK, Sethi, J, Varghese, A and Gairola, M (2022) Tri-modality therapy in advanced esophageal carcinoma: long-term results and insights from a developing world, institutional cohort. British Journal of Radiology. ISSN 0007-1285
![[thumbnail of Accepted Manuscript_BJR.docx]](https://eprints.keele.ac.uk/style/images/fileicons/text.png)
Accepted Manuscript_BJR.docx - Accepted Version
Restricted to Repository staff only until 21 December 2023.
Available under License Creative Commons Attribution Non-commercial.
Download (6MB)
Abstract
Objective: To evaluate treatment outcomes in patients from a low-middle income country (LMIC) with esophageal carcinoma who underwent esophagectomy after neoadjuvant chemoradiation (NACRT/S). Methods: Between 2010 and 2020, 254 patients (median follow-up: 53 months) met our inclusion criteria. Out-of-field nodal regions were determined by reviewing individual radiotherapy plans. Cox regression modelling was performed to analyze overall survival (OS) and recurrence-free survival (RFS), while pathological complete response (pCR) prediction utilized Poisson regression. Results: The median OS was 71.4 months (interquartile range: 19.6–∞), RFS did not reach the median and pCR rate was 46%. On multivariable Cox regression, BMI [0.93 (0.89–0.98); 0.94 (0.89–0.99)] and absence of out-of-field node with extranodal extension (ENE)[0.22 (0.09–0.53); 0.30 (0.12–0.75)] influenced OS and RFS, respectively. Age [1.03 (1.01–1.06)], nodal stage [cN2-3 vs cN0: 2.67 (1.08–6.57)] and adventitial involvement [2.54 (1.36–4.72)] also influenced OS, while involved margins [3.12 (1.24–7.81)] influenced RFS. On multivariable Poisson regression, non-CROSS-chemotherapy regimens [0.65 (0.44–0.95)] and residual primary disease on pre-surgical imaging [0.73 (0.57–0.93)] were significantly associated with pCR. The most frequently involved in-field and out-of-field nodal regions were the periesophageal and perigastric (greater and lesser curvature) regions, respectively. Conclusion: NACRT/S is feasible and effective in patients from LMIC. Out-of-field ENE merits further investigation as a prognostic factor since it significantly influenced both OS and RFS. Advances in knowledge: The results of clinical trials are replicable in LMICs. Out-of-field ENE is an independent prognostic factor for OS and RFS.
Item Type: | Article |
---|---|
Additional Information: | The final version of this article and all relevant information related to it, including copyrights, can be found on the publisher website. |
Subjects: | R Medicine > R Medicine (General) R Medicine > RC Internal medicine R Medicine > RC Internal medicine > RC0254 Neoplasms. Tumors. Oncology (including Cancer) |
Divisions: | Faculty of Medicine and Health Sciences > School of Medicine |
Depositing User: | Symplectic |
Date Deposited: | 07 Feb 2023 13:27 |
Last Modified: | 07 Feb 2023 13:27 |
URI: | https://eprints.keele.ac.uk/id/eprint/11897 |